Progressive Supranuclear Palsy: Improvement in Cognitive-Behavioral Disturbances and Motor-Function Disabilities Following Treatment With Antidepressants and Cholinesterase Inhibitors

Progressive supranuclear palsy (PSP) is a neurodegenerative disease that usually develops after the sixth decade of life, and the diagnosis is purely clinical except in cases of pathologically confirmed autopsies. A multidisciplinary approach to meet the patients’ complex needs is the current core t...

Descripción completa

Detalles Bibliográficos
Autores principales: Oyeka, Michelle, Ibilah, Terngu, Israel, Jacob, Gavito-Higuera, Jose, Salazar, Ricardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8279080/
https://www.ncbi.nlm.nih.gov/pubmed/34306851
http://dx.doi.org/10.7759/cureus.15641

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8279080/
https://www.ncbi.nlm.nih.gov/pubmed/34306851
http://dx.doi.org/10.7759/cureus.15641

Ejemplares similares